Here is a consolidated review of the most material insider stock transactions disclosed on Monday, January 26, 2026. The filings cover substantial purchases and sales by executives and 10-percent owners across a range of industries including consumer goods, healthcare, semiconductors, financial services and energy.
Top Buys
Under Armour, Inc. - Two 10-percent owners, Fairfax Financial Holdings LTD/CAN and WATSA V PREM ET AL, reported purchases of Class A and Class C common shares totaling $14.4 million. The acquisitions were executed between January 22 and January 26, 2026, at per-share prices spanning $6.1453 to $6.2968. The filings note the company has shown notable year-to-date appreciation, with shares up 27.8% and trading at $6.32 at the time of the disclosure.
Biodesix Inc. - Emeritus Director Jack W. Schuler, identified as a 10-percent owner, purchased 82,465 shares on January 22, 2026. Prices for these shares ranged from $10.675 to $11.10, with the total outlay listed as $903,560. Post-transaction holdings for Mr. Schuler include 1,463,210 shares in the Jack W. Schuler Living Trust and an additional 750,000 shares in the Jack W. Schuler 2025 GRAT, both of which he serves as sole trustee.
Mission Produce, Inc. - Globalharvest Holdings Venture Ltd, a 10-percent owner, disclosed purchases valued at $4.05 million. The reported transactions occurred on January 21 and January 22, 2026. Specifically on January 21, Globalharvest bought 237,270 shares at prices ranging from $12.61 to $13.00 for a total of $3,065,057, bringing its direct holdings to 9,698,858 shares. Mission Produce stock was reported to have gained 8.2% over the prior week and 11.7% in the preceding six months.
Abbott Laboratories - Chairman and CEO Robert B. Ford acquired 18,800 shares of common stock on January 23, 2026. The purchase prices ranged from $106.735 to $107.485 per share, with a reported weighted average of $107.1259 and an aggregate purchase value of $2,013,966. After the buys, Mr. Ford directly holds 253,305 shares and indirectly holds an additional 216,203 shares through the Ford Family Trust.
Top Sells
UWM Holdings Corp. - CEO Mat Ishbia together with SFS Holding Corp, a 10-percent owner, sold a combined 1,898,622 shares of Class A common stock across three transactions that took place between January 22 and January 26, 2026. The collective sales generated roughly $11.1 million, with per-share proceeds falling between $5.75 and $5.87. The filings indicate the dispositions were evenly split, with 632,874 shares sold on each of the three days. The reported average sale prices declined across the sequence: $5.87 on January 22, $5.85 on January 23, and $5.75 on January 26.
Gilead Sciences - Chairman and CEO Daniel Patrick O'Day sold 115,640 shares on January 23, 2026, at $135 per share for proceeds of $15.6 million. The SEC filing specifies the sale was made under a previously adopted Rule 10b5-1 trading plan dated February 28, 2025. At the time of the disclosure, Gilead was trading near its 52-week high of $137.84 and had returned 46.54% over the trailing 12 months.
Micron Technology, Inc. - Manish H Bhatia, Executive Vice President of Global Operations, reported sales totaling 26,623 shares on January 22, 2026, realizing $10,410,771. The disposition occurred in six tranches: 5,128 shares at $388.78; 7,200 shares at $389.91; 8,500 shares at $391.01; 2,200 shares at $392.84; 1,295 shares at $394.92; and 2,300 shares at $395.87.
Procter & Gamble - Chief Brand Officer Marc S. Pritchard sold 95,903 shares on January 23, 2026, producing approximately $14.5 million. The reported sale prices ranged from $150.36 to $151.60, with a weighted average price of $151.1495. The filing also shows Mr. Pritchard exercised options on the same day to acquire an identical number of shares at an exercise price of $80.29 per share, representing a total exercise cost of $7.7 million.
Halliburton - Director, President and CEO Jeffrey Allen Miller sold 171,200 shares on January 23, 2026, at $34.96 per share, yielding $5.98 million in gross proceeds. On the same day Mr. Miller exercised options to acquire 171,200 shares at an exercise price of $31.44, for a total exercise value of $5.38 million. After these transactions, Mr. Miller directly owns 1,101,243.02 shares. The filing notes Halliburton shares were trading close to a 52-week high of $35.55 and had risen more than 53% over the past six months.
Interpretation and Context for Investors
Insider transactions can offer one lens into how corporate insiders and large shareholders are positioning their stakes, but they do not provide definitive conclusions on future performance.
- Insider buying is often viewed as a sign of confidence, but the filings here reflect a range of circumstances across companies and participants.
- Insider selling can reflect varied motivations - the filings in this batch document conventional dispositions as well as sales executed under a Rule 10b5-1 plan and option exercises coordinated with share sales.
- Given the diversity of motives and mechanisms recorded in these filings, investors should treat insider activity as one input among many when assessing a company's outlook.
For informed decision-making, insider activity should be combined with fundamental analysis, industry trends, and consideration of broader market conditions rather than used in isolation.